Novo Path Medical For Profit
The Company develops preventive airway management solutions aiming to minimize complications and improve medical care of mechanically ventilated patients. The company is developing its flagship product, the NovoPath™, a disposable endotracheal tube (ETT) lining enabling the instant replacement of the entire ETT inner surface, thus preventing the accumulation of bacteria, fungi and other bio burden.
Founded Date:
2012-01-01
Headquarters:
Nazareth, HaZafon, Israel
Technology:
Biomarker panels
Employee Number:
11-50
Industry:
Clinical Data Management
Estimated Revenue:
$1M to $10M
Number Of Exists:
N/A
Funding Status:
Early Stage Venture
Investor Type:
Company
Investment Stage:
N/A